SEDALOR

This brand name is authorized in Austria, Cyprus, Malta

Active ingredients

The drug SEDALOR contains one active pharmaceutical ingredient (API):

1 Lormetazepam
UNII GU56C842ZA - LORMETAZEPAM

Lormetazepam is a benzodiazepine with anxiolytic, muscle relaxant, sedative and hypnotic properties. Clinical studies have shown minimal effects on REM sleep and on psychomotor performance on the day after treatment with lormetazepam. Lormetazepam is indicated for the short term treatment of insomnia.

Read about Lormetazepam

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SEDALOR Solution for injection / infusion MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05CD06 Lormetazepam N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: MT Medicines Authority Identifier(s): MA1080/00101

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.